Emmanuel Navarro Flores

Dr. Emmanuel Navarro Flores

University of Valencia
+4
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Journal of Tissue Viability
Verified
Journal Article
Closed access
Emmanuel Navarro FloresEmmanuel Navarro Flores
Emmanuel Navarro Flores
Jose Miguel Morales-AsencioJose Miguel Morales-Asencio
Jose Miguel Morales-Asencio
JCJosé Antonio Cervera-Marín
José Antonio Cervera-Marín
MLMª Teresa Labajos-Manzanares
Mª Teresa Labajos-Manzanares
Gabriel Gijon-NogueronGabriel Gijon-Nogueron
Gabriel Gijon-Nogueron

1 March 2018 in Disease-a-Month
Verified
Journal Article
Closed access
DRDavid Rodriguez
David Rodriguez
NTNatalia Tovaruela-Carrión
Natalia Tovaruela-Carrión
Daniel López-LópezDaniel López-López
Daniel López-López
Patricia Palomo LópezPatricia Palomo López
Patricia Palomo López
Carlos Romero-MoralesCarlos Romero-Morales
Carlos Romero-Morales
César Calvo LoboCésar Calvo Lobo
César Calvo Lobo

6 March 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
Pilar Pérez-RosPilar Pérez-Ros
Pilar Pérez-Ros
Emmanuel Navarro FloresEmmanuel Navarro Flores
Emmanuel Navarro Flores
Ivan Julian-RochinaIvan Julian-Rochina
Ivan Julian-Rochina
FMFrancisco Miguel Martínez-Arnau
Francisco Miguel Martínez-Arnau
Omar CauliOmar Cauli
Omar Cauli
Background and Objective: Diabetes mellitus (DM) is a common long-term disease which can be related with salivary amylase levels. DM has recently been associated with salivary amylase diagnostics that could further impair diagnoses in the diabetic population, as well as being an interesting alternative to traditional methods of determine glucose levels. The main advantage of this method is related to the fact that it is a fast diagnostic method. The DM population experiences changes to their metabolism which affects their salivary parameters, making this an alternative procedure for diagnosis and follow-up of the illness due to the non-invasive nature of salivary analyzes. The objective of this review is to summarize the evidence regarding the changes in salivary amylase and glucose levels, and their relationship with blood markers of glycemic control used in clinical settings such as blood glucose and glycated hemoglobin. The differences in salivary amylase levels depending on the method of saliva collection under fasting or non-fasting conditions. The changes in salivary amylase depends on the type of diabetes, the type of insulin treatment or the quality of glycemic control. Conclusions: Salivary amylase concentration is increased in diabetic patients in most of the studies and salivary glucose concentration in all studies in both fasting and non-fasting (post-prandial) conditions. Salivary amylase and glucose concentration represent potential non-invasive biomarkers to evaluate glycemic control and clinical management of diabetic patients, although it is necessary to evaluate the influence of potential modulating factors such as age, duration diseases, sex and the effects of pharmacological treatments in these outcomes which remained to be elucidated.

5 November 2020 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
Emmanuel Navarro FloresEmmanuel Navarro Flores
Emmanuel Navarro Flores
Omar CauliOmar Cauli
Omar Cauli
Background and Objective: Diabetic foot syndrome (DFS) is a common long-term complication of diabetes mellitus. DFS has recently been associated with adverse effects that could further impair the quality of life of diabetic patients, and increase the social and economic burden, morbidity, and premature mortality of the disease. The main physio-pathological basis of DFS is due to diabetesinduced neuropathy and angiopathy in the lower limbs and feet. Patients diagnosed with DFS must significantly modify their daily habits in order to cope with signs and symptoms of DFS and this can alter their quality of life. The objective of this review is to summarize the evidence regarding the economic, physical and social limitations which can affect the quality of life (QoL) in patients with DFS, the effects of ulcers and amputations on QoL outcomes. Results: Different aspects related to DFS such as physical alterations, psychological complaints and even disorders, socio-economic difficulties can affect the quality of life of these patients. However, the QoL related to low socio-economic factors gave mixed results and physical activity, education and type of footwear can influence the outcomes. There is a general gender-dependent higher prevalence of DFS in men, although it depends on the geographical area. DFS often co-occurs with other diabetes-induced complications (retinopathy, nephropathy and cardiovascular disorders) and comorbid obesity generally worsens it. Conclusions: Accessibility to health services aimed at reducing inequalities and constant health education and promotion and care regarding psychological and socio-economic issues should be continuously undertaken for individuals with DFS in order to improve their QoL.

29 January 2020 in Foot & Ankle International
Verified
Journal Article
Closed access
PDF file
Ruben Sanchez-GomezRuben Sanchez-Gomez
Ruben Sanchez-Gomez
RVRicardo Becerro de Bengoa Vallejo
Ricardo Becerro de Bengoa Vallejo
MIMarta Elena Losa Iglesias
Marta Elena Losa Iglesias
César Calvo LoboCésar Calvo Lobo
César Calvo Lobo
Emmanuel Navarro FloresEmmanuel Navarro Flores
Emmanuel Navarro Flores
Daniel López-LópezDaniel López-López
Daniel López-López
Functional hallux limitus (FHL) refers to dorsiflexion hallux mobility limitation when the first metatarsal head is under loading conditions but not in the unloaded state. The goal of the study was to evaluate 3 common manual tests (Buell, Dananberg, and Jack tests) for assessing first metatarsophalangeal joint (MPJ) mobility and determining the normal values needed to detect FHL, and clarify the signs and symptoms associated with this pathology. Forty-four subjects were included in this reliability study. Subjects were divided into healthy control (non-FHL) and FHL groups according to the Buell first MPJ limitation values in addition to signs and symptoms derived from the literature. In both groups, we measured the mobility in the Buell, Dananberg, and Jack tests using a goniometer; their intraclass correlation coefficients (ICCs), sensitivities, and specificity indexes were also calculated. All techniques showed high reliability across measurement trials with ICCs ranging from 0.928 to 0.999. The optimal mobility grades for predicting FHL were 68.6 ± 3.7 degrees, 21 ± 5.9 degrees, and 25.5 ± 6.5 degrees (mean±SD) (P < .05) for the Buell, Dananberg, and Jack tests, respectively. Normal and limited mobility values were established for assessing FHL using each technique. The sensitivity and specificity data were perfect for the Dananberg and Jack tests, thus identifying these tests as specific and valid tools for use in FHL diagnosis. Pinch callus was the sign most associated with FHL. Level II, comparative series.

1 October 2021 in Disease-a-Month
Verified
Journal Article
Closed access
Carlos Romero-MoralesCarlos Romero-Morales
Carlos Romero-Morales
MBMaría Bravo-Aguilar
María Bravo-Aguilar
VAVanesa Abuin
Vanesa Abuin
Jaime Almazán PoloJaime Almazán Polo
Jaime Almazán Polo
César Calvo LoboCésar Calvo Lobo
César Calvo Lobo
Emmanuel Navarro FloresEmmanuel Navarro Flores
Emmanuel Navarro Flores